Literature DB >> 23966747

Multicentric Castleman's disease in a Ghanaian adult.

Y A Dei-Adomakoh1, C Segbefia, I Ekem, A Taylor.   

Abstract

Castleman's disease is a rare cause of lymphoid hyperplasia that may result in localized symptoms or an aggressive, multisystem disorder that can mimic other diseases like lymphoma or tuberculosis. We describe a case of a 55-year-old Ghanaian male who was successfully diagnosed and managed for multicentric Castleman's disease with combination chemotherapy.

Entities:  

Keywords:  Plasma cell; Rituximab; chemotherapy; lymphadenopathy; multicentric Castleman's disease

Mesh：

Substances：

Year:  2013        PMID： 23966747      PMCID： PMC3743110     

Source DB:  PubMed          Journal:  Ghana Med J        ISSN： 0016-9560


  19 in total

1.  Highly active antiretroviral therapy alone may be an effective treatment for HIV-associated multi-centric Castleman's disease.

Authors:  Siow Ming Lee; Simon G Edwards; Daniella N Chilton; Alan Ramsay; Robert F Miller
Journal:  Haematologica       Date:  2010-08-26       Impact factor: 9.941

2.  A rare association of Castleman's disease and nephrotic syndrome.

Authors:  I Tazi; M Rachid; A Quessar; S Benchekroun
Journal:  Saudi J Kidney Dis Transpl       Date:  2011-01

Review 3.  Fifty years of multicentric Castleman's disease.

Authors:  Ashita Waterston; Mark Bower
Journal:  Acta Oncol       Date:  2004       Impact factor: 4.089

4.  Splenectomy-induced long-term remission in a patient with multicentric Castleman's disease.

Authors:  M M E M Bos; L M van den Berg; A W F M van Leeuwen; E F M Posthuma
Journal:  Neth J Med       Date:  2009-09       Impact factor: 1.422

Review 5.  Castleman's disease of the lung: radiographic, high-resolution CT, and pathologic findings.

Authors:  J R Barrie; J C English; N Müller
Journal:  AJR Am J Roentgenol       Date:  1996-05       Impact factor: 3.959

6.  Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody.

Authors:  J T Beck; S M Hsu; J Wijdenes; R Bataille; B Klein; D Vesole; K Hayden; S Jagannath; B Barlogie
Journal:  N Engl J Med       Date:  1994-03-03       Impact factor: 91.245

7.  Castleman disease in the 21st century: an update on diagnosis, assessment, and therapy.

Authors:  Frits van Rhee; Katie Stone; Susann Szmania; Bart Barlogie; Zeba Singh
Journal:  Clin Adv Hematol Oncol       Date:  2010-07

Review 8.  Neoadjuvant radiotherapy of primary irresectable unicentric Castleman's disease: a case report and review of the literature.

Authors:  Iris A C de Vries; Marjolein M S van Acht; Thomas B J Demeyere; Marnix L M Lybeert; Jean-Paul de Zoete; Grard A P Nieuwenhuijzen
Journal:  Radiat Oncol       Date:  2010-02-02       Impact factor: 3.481

Review 9.  Multicentric Castleman's disease in HIV infection: a systematic review of the literature.

Authors:  Eleni E Mylona; Ioannis G Baraboutis; Lazaros J Lekakis; Ourania Georgiou; Vasilios Papastamopoulos; Athanasios Skoutelis
Journal:  AIDS Rev       Date:  2008 Jan-Mar       Impact factor: 2.500

10.  Update on HHV-8-Associated Malignancies.

Authors:  Meena Sunil; Erin Reid; Mary Jo Lechowicz
Journal:  Curr Infect Dis Rep       Date:  2010-03-26       Impact factor: 3.725
View more
  1 in total

1.  Sjögren's and plasma cell variant Castleman disease: a case report.

Authors:  Yvonne A Dei-Adomakoh; Leslie Quarcoopome; Afua D Abrahams; Catherine I Segbefia; Dzifa I Dey
Journal:  Ghana Med J       Date:  2018-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.